@gottafigurelikeagrandpa's GLP-1 maintenance claims checked

What does this viral video actually claim?

@gottafigurelikeagrandpa's TikTok with 436K views shows him expressing hope about keeping his weight loss results while on GLP-1 medications. The brief video doesn't make specific medical claims but touches on a common concern: whether weight loss from drugs like semaglutide or tirzepatide is sustainable long-term.

The creator's casual "I hope I keep it lmao" reflects what many patients wonder about. Will the weight stay off? What happens if you stop the medication? His uncertainty is actually more honest than many GLP-1 success stories that skip over the maintenance reality.

What does the science say about keeping GLP-1 weight loss?

The data on this is pretty clear, and it's not what most people want to hear. Weight regain after stopping GLP-1 medications is the rule, not the exception.

The STEP 1 extension study (Rubino et al., Diabetes Care, 2021) followed patients who stopped semaglutide after 68 weeks of treatment. Those who switched to placebo regained 66% of their lost weight within 52 weeks. The STEP 4 withdrawal trial showed similar results: participants who stopped semaglutide regained 6.9% of their body weight while those who continued lost an additional 2.4%.

For tirzepatide, the SURMOUNT-4 trial (Jastreboff et al., Nature Medicine, 2022) showed that patients who stopped the medication after 36 weeks regained most of their weight loss. Those who continued tirzepatide maintained their 20.9% weight reduction.

What your grandfather got right and wrong

His uncertainty is actually spot-on with the science. Maintaining GLP-1 weight loss without continuing the medication is difficult for most people, and hoping isn't really a strategy.

But the video misses the bigger picture about what "keeping it" means. The research shows that staying on these medications long-term is typically necessary for sustained weight loss. The SELECT trial (Lincoff et al., NEJM, 2023) demonstrated that continued semaglutide use maintained cardiovascular benefits over 40 months, suggesting these aren't short-term fixes.

Your grandfather's casual approach doesn't acknowledge that successful maintenance usually requires ongoing medical management, not just hope and good intentions.

What patients actually need to know about GLP-1 maintenance

These medications work by changing how your brain responds to hunger and satiety signals. When you stop taking them, those changes largely reverse within months.

Real-world data from electronic health records shows that patients who stay on GLP-1 medications for two years maintain significantly more weight loss than those who stop early. The average person needs to think of these as long-term treatments, not temporary weight loss aids.

Some patients do maintain weight loss after stopping, but they're outliers. The STEP 1 data shows only about 20% of patients maintained their full weight loss one year after discontinuation. Most successful maintenance involves continued medication plus lifestyle changes.

The cost and insurance coverage issues your grandfather doesn't mention are real barriers. Many patients cycle on and off these medications based on coverage changes, creating a yo-yo pattern that's less effective than consistent treatment.